Evidence map›Paper›PMID 37060045›Full record

ArticleBMC neurology2023

Cryptogenic stroke as a working diagnosis: the need for an early and comprehensive diagnostic work-up.

Maurizio Acampa, Pietro Enea Lazzerini, Simona Lattanzi, Marta Rubiera

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Targeting Neurovascular Pathways: Gene Therapy as a Novel Treatment for Vascular Dementia After Stroke.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Maurizio AcampaStroke Unit, Department of Emergency-Urgency and Transplants, Azienda Ospedaliera Universitaria Senese, "Santa Maria alle Scotte" General-Hospital, Siena, Italy. M.Acampa@ao-siena.toscana.it.
Pietro Enea LazzeriniDepartment of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Simona LattanziDepartment of Experimental and Clinical Medicine, Neurological Clinic, Marche Polytechnic University, Ancona, Italy.
Marta RubieraStroke Unit, Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain.
Azienda Ospedaliera Universitaria Senese · ITMarche Polytechnic University · ITUniversity of Siena · ITVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study, the causes of ischemic stroke were identified in 43% of cryptogenic stroke patients monitored with implantable cardiac monitor (ICM), but one-third of these patients had non-cardioembolic causes. These results suggest the need for an early and comprehensive diagnostic work-up before inserting an ICM.

Indexed as

Atrial FibrillationIschemic StrokeStrokeElectrocardiographyElectrocardiography, AmbulatoryHumansAtrial cardiopathyAtrial fibrillationCryptogenic strokeImplantable cardiac monitorNoncardioembolic strokeNonstenosing atherosclerosis

Identifiers

PMID37060045
PMCPMC10103391
OpenAlexW4365511934

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.